Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer
December 15, 2014 at 08:44 AM EST
Immunomedics, Inc., (Nasdaq: IMMU) today announced that a new pretargeted imaging system developed by IBC Pharmaceuticals, Inc. (IBC), ...